Matinas BioPharma’s Post

PSI is the expert #CRO in #antifungals and proud to support Basilea Pharmaceutica in executing the Phase III in #candidemia and invasive #candidiasis.

🌍💛 Today is World Hepatitis Day! 💛🌍 According to WHO, "Over 350 million people in the world are living with viral hepatitis. Each year over a million people lose their lives because of conditions related to acute hepatitis and chronic infection that cause liver cancer and cirrhosis. Chronic hepatitis B and C infections are the leading cause of liver cancer." As we work together across the globe to raise awareness, it's important to remember that staying protected starts with education. Ansell has leveraged our over 130 year history to develop proprietary technologies and educational programs for high quality personal protective equipment (PPE) to help prevent the spread of infection, supporting safer clinical environments for you and your patients. Our commitment is to support health and well-being every day of the year patients and clinical teams, delivering the highest quality protection products supported by easy to use and effective educational resources that help increase your team’s safety outcomes and satisfaction levels. #AnsellProtects #knowthedifference #WorldHepatitisDay #HandProtection #HealthAndSafety" Learn More: https://bit.ly/4bIdyYH Resource: https://bit.ly/3xWIy9J.

World Sickle Cell Day is an international awareness day commemorated every year on 19 June, to alert the global public about sickle cell disease. Various global and local organisations come together during this day to promote awareness campaigns and activities which recognise the necessity of the early diagnosis of sickle cell disease, its treatment, and preventive tips to avoid the ailment. The Necessity for the Awareness of Sickle Cell Disease Sickle cell disease is one of the majorly occurring monogenic diseases (over 3,00,000 affected births worldwide). The majority of them are seen in low- and middle-income countries

Did you know that approximately 1 in 200 newborns worldwide are affected by congenital cytomegalovirus (cCMV)? 🤔 While most of these cases remain asymptomatic, the immune system plays a crucial role in controlling the infection. 📰 In a groundbreaking study published in The Journal of Clinical Investigation, Grassmann concluded, "innate-like programming of conventional T cells may have evolved to combat congenital CMV infection." These insights could inform the development of future therapies. You can read the full article in our Newsroom: https://lnkd.in/e3gN8mhy #StopCMV #CMVAwareness #CMVResearch

Many new compounds are in advanced stages of clinical development for the treatment of chronic hepatitis B. Will we finally be able to achieve functional cure of HBV infection in a large number of our patients? Harry Janssen and myself offer our view on the future of combination treatment for chronic hepatitis B in this Science Behind the Study article now published in NEJM Group.

Number of new cases of Hepatitis C virus (#HCV) has been growing at an alarming rate in the past decade - it has been doubling since 2014! Baebies has been awarded a 6-month SBIR Phase I contract from the Centers for Disease Control and Prevention (#CDC) to develop a sample-to-answer workflow for the detection of HCV from fingerstick whole blood samples. This workflow will be evaluated on Baebies' point-of-care digital microfluidic platform, FINDER - the same multifunctional platform on which we have demonstrated chemistry and coagulation assays. The system will use #RT-PCR to provide results in under 30 minutes, offering a confirmatory diagnosis of viremic HCV infection with a single test. We are grateful for CDC's support in advancing this important diagnostic innovation. To know more or to collaborate with us please email info@baebies.com

Is it isothermal amplification? No, it is PCR. Is it qualitative? No, it is quantitative PCR. Is the specimen in a collection medium? No, it is more complex, direct fingerstick blood. Can I get results in as fast as 1 hr? No, no, it takes under 30 mins. Yet another addition to the multifunctional capabilities of FINDER. Thanks to Centers for Disease Control and Prevention for their support in furthering the development of this cartridge.

🔎 The 2024 Rare Disease Highlights Countdown continues! The impact of COVID-19 continues to shape our understanding of rare diseases. A recent study explored the potential link between COVID-19 infection and the development of neuromuscular disorders like chronic inflammatory demyelinating polyneuropathy (#CIDP). Researchers focused on patients who experienced weakness or paresthesia following a COVID-19 infection. Using advanced diagnostics such as nerve conduction studies and needle electromyography, they aimed to better characterize this connection and its implications for care. 🔗 Read the full story: https://bit.ly/4095vS8 #RareDisease

🧪 Research into diagnostics of infections was named as one of the priority areas in the WHO AMR global research agenda 2023. 🦠 Our fourth slide deck of the 'WHO AMR Priorities' series looks deeper into some of the key areas of infectious disease diagnostic research where the WHO is calling for more strategic interventions, such as implementation of point-of-care testing, including for detection of Neisseria gonorrhoeae. #WHO #AMR #Diagnostics

Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia Eleftherios Gkioulekas at the 2024 Infectious Disease World Conference, presenting our study on the Hazan, Stone, and Babalola case series of hypoxemic COVID-19 patients, treated with ivermectin-based multidrug protocols. The presentation is focused on reviewing the details of the three case series, the protocols used, the case series demographic characteristics, and our statistical analysis establishing the strength of association between treatment and reduction in hospitalizations and deaths. Watch the full presentation here: https://shorturl.at/NkINp Read the study here: https://lnkd.in/gEaNm7zy #MFEducation